Clinical Trial Update: Hostility and Coronary Risk--Role of Weak Vagal Function

View source ↗

Summary

A completed NHLBI-sponsored clinical trial examines the role of weak vagal function in hostility-related coronary risk. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED